Second generation Car T-cell therapy trialled in patients

A new CAR T-cell therapy developed by scientists at UCL, including Dr Claire Roddie (UCL Cancer Institute), has fewer ‘toxic’ side-effects and is more durable, targeting and killing cancer cells for longer, concludes a Phase I clinical trial of patients at UCLH.

Read: BBC News, More: UCL News, Listen: BBC Radio 4’s ‘Midnight News’ (from 21 mins 39 secs), BBC World Service Radio’s ‘The Newsroom’ (from 20 mins 20 secs)